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Abstract Addition of phosphatidylcholine-hydrolyzing phospho- 
lipase C (PC-PLC) to cultured glial cells increased the levels of 
nerve growth factor (NGF) mRNA and the amount of cell-se- 
creted NGF. The effect of PC-PLC was 2.5 times higher than 
that elicited by 41B-phorbol 121B-myristate 13a-acetate. In cells 
in which protein kinase C (PKC) was fully inhibited or down- 
regulated, the effect of PC-PLC was reduced - though still evi- 
dent - and similar to that exerted by sphingosine. Results thus 
indicate that PC-PLC induces the synthesis of NGF by glial cells 
by a PKC-dependent and PKC-independent mechanisms. 
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1. Introduction 
Nerve growth factor (NGF) is a neurotrophic protein re- 
quired for the development and survival of several populations 
of neurons [1]. In the central nervous ystem, NGF is synthe- 
sized by certain neurons, but during brain development and 
under different pathological terations of the nervous ystem, 
there is a local increase in the production of NGF by astrocytes 
[2-5]. Thus, substantial present effort is directed toward an 
understanding of the influences that control NGF synthesis, 
because of the possibility that increasing the endogenous syn- 
thesis of NGF might provide clinical advantage indegenerative 
diseases of central nervous ystem [6]. However, little is known 
about he effectors that induce the synthesis of NGF by those 
cells and about how this synthetic process is up-regulated. It 
seems that several NGF-inducing agents act through different 
pathways. One of them is the signalling network involving the 
activation of protein kinase C (PKC). Studies performed with 
cultured astrocytes and fibroblasts have shown that 4fl-phorbol 
12fl-myristate 13~-acetate (PMA), a well-documented PKC ac- 
tivator, induces the synthesis and secretion of NGF, and this 
effect is counteracted by PKC inhibitors like H-7 or H-9 [7,9]. 
PMA induces the expression of c-fos, the product of which 
enhances NGF synthesis by the same route as PMA [5,9,10]. 
PKC is physiologically activated by diacylglycerol (DAG) 
resulting from agonist-induced hydrolysis of inositol phosphol- 
ipids [11]. However, this DAG rapidly disappears and seems to 
be responsible for a transient activation of PKC [12]. In con- 
trast, hydrolysis of other membrane phospholipids, particularly 
phosphatidylcholine (PC), produces DAG at a relatively later 
phase. This DAG may be the responsible for the sustained 
activation of PKC that leads to long-term cellular responses 
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[13]. Mechanisms of cellular response to PC hydrolysis have 
been demonstrated to occur in many cell types (reviewed in 
[12,14]). Despite xtensive studies, the biochemical mechanisms 
underlying signal-induced activation of PC breakdown are still 
poorly defined. Phospholipase C (PLC)-catalyzed hydrolysis of 
PC has been shown to be activated in response to a number of 
agonists [15], in transformed cells [16] and in signalling cascades 
triggered by growth factors [17]. PC-PLC provides a positive 
signal for PKC by inducing its translocation to membrane 
though not its down-regulation [16], It has also been shown that 
PC hydrolysis by a PC-PLC mimics the ability of carbachol to 
inhibit adenylyl cyclase [18]. Furthermore, a role of PC-specific 
phospholipase D (PLD) in signal transduction has been de- 
scribed [13,19]. 
In the present study we investigated the possible relationship 
between PC hydrolysis and PKC activation in the control of 
NGF synthesis by astrocytes. Previous experimental evidence 
showed that activation of PKC with PMA stimulated NGF 
synthesis by glial cells [7] while exogenously added PC-PLC was 
able to activate PKC in fibroblasts [18]. This provinded us a 
tool to investigate whether NGF synthesis by glial cells depends 
on PC breakdown. 
2. Experimental 
2. I. Culture conditions 
Primary cultures of rat brain glial cells were prepared from cerebral 
hemispheres of l-2-day-old rat pups. Cerebral hemispheres were dis- 
sected in phosphate buffered saline (PBS) supplemented with 0.33% 
glucose and treated with trypsin (5 mg/ml, 30 rain at 37°C). Trypsin was 
subsequently inhibited by the addition of 10% foetal calf serum (FCS), 
before treatment with DNase I (10 flg/ml, 5 min at 37°C). Brain cells 
were dissociated by fluxation with a Pasteur pipette and next sedi- 
mented by low speed centrifugation (1000 × g, 5 rain). The pellet was 
gently resuspended, and cells were seeded at a density of 3 × 104 cells/ 
cm 2. All plastic supports were previously coated with 5 pg/ml poly°L- 
ornithine in water. Cells were cultured for 3 weeks in basal medium 
containing a mixture of Dulbecco's modified Eagle medium and Ham's 
F 12 (l/l, v/v), supplemented with 0.66% glucose, 5 pg/ml streptomycin, 
5 U/ml penicillin and 10% FCS. Three days before the experiment, FCS 
was removed and cells were transferred toa chemically defined medium 
consisting of basal medium supplemented with 25/lg/ml insulin, 100 
pg/ml human transferrin, 20 nM progesterone, 50~M putrescine and 
30 nM sodium selenite. Immunocytochemical studies howed that 90% 
of cultured cells were positive for glial fibrillary acidic protein, indicat- 
ing that cultures were largely enriched in astrocytes. 
2.2. Assay of NGF and NGF rnRNA 
Cell supernatants were collected 24 h after the different treatments 
described in the text and diluted in 1 volume of PBS containing 0.1% 
Tween-20 and 0.5% gelatin. NGF released by the cells was assayed in 
triplicate, with a double-site-ELISA, using a monoclonal anti-NGF 
antibody, coupled or not to fl-galactosidase (Boehringer Manheim), 
according to [20]. Northern blot analysis was performed by standard 
procedures [7]. After 6 h of treatment, total RNA was extracted from 
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cells by the LiCl/urea method. Glyoxal-treated RNAs were fractionated 
in agarose gel, transferred to a nylon membrane by capillary blotting, 
and hybridized with a 32p-labelled NGF cDNA and a amyloid precur- 
sor protein (APP) cDNA, used to verify the loading of the gels. 
2.3. Identification fPKC by immunoblotting 
Glial cells (treated as described in the legend to Fig. 3) were scraped 
into 0.5 ml of ice-cold 50 mM Tris-HCl, pH 7.4, 5 mM EDTA, 10 mM 
2-mercaptoethanol containing 1/,tg/ml leupeptin, 1/tg/ml aprotinin, 10 
pg/ml benzamidin, 5 pg/ml soybean tripsin inhibitor and 0.1 mM 
PMSF, and rapidly centrifuged at 5,000 × g for 5 min to eliminate 
debries. Following denaturation i SDS sample buffer, proteins were 
resolved in a 8% SDS-PAGE and transferred electrophoretically onto 
nitrocellulose membranes (Bio-Rad). Membranes were blocked with 
5% of fat-free dried milk and incubated with 2 pg/ml of specific anti- 
PKC antiserum (clone MC5, Amersham International). Following in- 
cubation with horseradish conjugated anti-mouse antibody, the blots 
were developed with an enhanced chemiluminescence detection kit 
(Amersham International). 
2.4. Other chemicals 
Tissue culture plastic wares were purchased from Nunc (Denmark), 
culture media from Gibco (France) and FCS from Eurobio (France). 
PC-PLC and bisindolylmaleimide (GF 109203X) were from Calbio- 
chem (USA). Sphingosine and most other eagents were obtained from 
Sigma Chemicals (USA). 
3. Results 
3.1. PC-PLC enhances the synthesis of NGF 
Cultured glial cells were treated for 24 h with different doses 
of exogenously added PC-PLC from Bacillus cereus and NGF 
levels were determined in the supernatant media 24 h later. 
Results presented in Fig. 1 show a dose-dependent and satura- 
ble increase in the extracellular levels of NGF, which become 
maximal at 0.5 U/ml of PC-PLC. Doses over 1 U/ml were toxic 
to cells. Stimulation of cells with 100 nM of PMA was quanti- 
tatively lower than that induced by PC-PLC (Fig. 1). 
In order to determine whether PC-PLC had a corresponding 
on the pool of NGF transcripts, total RNA was extracted from 
cells pretreated with or without the enzyme. Northern blot 
analysis showed that PC-PLC produced a marked increase in 
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Fig. 1. Effect of increasing concentrations of PC-PLC on the produc- 
tion of NGF. Olial cells were incubated with no additions, PMA (100 
nM), or PC-PLC (0.1 U/ml, 0.25 U/ml, 0.5 U/ml and 1 U/ml). The 
medium was collected after 24 h and NGF was quantified by double- 
site ELISA. Values are means + S.D. of 3 independent experiments 
assayed in triplicate. 
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Fig. 2. Accumulation of NGF mRNA in astrocytes. Constant amounts 
of total RNAs were fractionated on an agarose gel, blotted and hybrid- 
ized with a radiolabelled NGF cDNA probe. Lane 1: control; lane 2: 
PMA 100 nM; lane 3: PC-PLC 0.5 U/ml; lane 4: cells treated with PMA 
500 nM for 48 h and the last 24 h with PMA 100 nM; and lane 5: cells 
treated with PMA 500 nM for 48 h and the last 24 h with PC-PLC 0.5 
U/ml. Essentially identical results were obtained in two independent 
experiments. 
NGF mRNA,  as compared to controls, indicating that PC-PLC 
is able to promote NGF synthesis (Fig. 2, lanes 1 and 3). This 
effect is more potent than that elicited by PMA (Fig. 2, lane 2). 
3.2. The induction of NGF synthesis by PC-PLC is partially 
dependent on PKC 
To investigate whether PKC activation is required for the 
PC-PLC-triggered induction of NGF synthesis, PKC was 
down-regulated in glial cells by pretreating the cell cultures with 
a supramaximal dose of PMA (500 nM) for 48 h. This treatment 
completely removed PKC from astrocytes as determined by 
Western blot analysis with a specific monoclonal anti-PKC 
antibody (Fig. 3). Interestingly, induction of NGF synthesis by 
PC-PLC emerged reduced but not abolished, in cells in which 
PKC was down-regulated (Table 1), whereas NGF induction 
Table 1 
Effect of PKC inhibition and down-regulation a d effect of sphingosine 
on the levels of cell-secreted NGF measured by ELISA 
Additions NGF pg/ml 
None 
PMA 100 nM 
PC-PLC 0.5 U/ml 
PMA 100 nM+ BIM 2pM 
PC-PLC 0.5 U/ml + BIM 2 pM 
PMA 500 nM (48 h) + PMA 100 nM 
PMA 500 nM (48 h) + PC-PLC 0.5 U/ml 
Sphingosine 10 pM 
34.68 + 10 
196.51 + 90 
490.54 + 119 
37.41 + 3 
130.30 _+ 23 
32.87 + 2 
171.50 + 27 
164.80 + 12 
The values represent the means _+ S.E.M. of 2 independent experi- 
ments assayed in triplicate. 
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Fig. 3. Western blot analysis of PKC levels in cell lysates. Lane 1: 
control; lane 2: PMA 100 nM; lane 3: cells treated with PMA 500 nM 
for 48 h and the last 24 h with PMA 100 nM; and lane 4: cells treated 
with PMA 500 nM for 48 h and the last 24 h with PC-PLC 0.5 U/ml. 
as elicited by PMA was completely abolished in down-regu- 
lated cells. This effect was also observed at the mRNA levels, 
as determined by Northern blot analysis (Fig. 2, lanes 4 and 5). 
Further experimental evidence to support these data was 
obtained by the use of bisindolylmaleimide (BIM), a potent and 
higly specific inhibitor of PKC [21]. Inhibition of PKC by BIM 
completely abolished the increase in NGF levels induced by 
PMA, whereas treatment of cells with BIM only reduced in part 
the increase in NGF levels produced by PC-PLC (Table 1). 
Hence, PKC seems to be only partially involved in the NGF 
inducing response licited by PC-PLC. 
3.3. Sphingosine increases the production of NGF 
In order to study whether another mechanism of signal 
transduction could be involved in the synthesis of NGF, we 
determined the effect of sphyngosine on NGF secretion by glial 
cells. Results reported in Table 1 show that sphingosine in- 
creases the extracellular levels of NGF to the same extent as 
PC-PLC does in PKC down-regulated cells. 
4. Discussion 
Despite the recent efforts performed to unravel the mecha- 
nisms of NGF induction, the signal-transducing pathways lead- 
ing to the synthesis of this neurotrophic protein remain largely 
unknown. Many of the agents which are able to stimulate NGF 
synthesis are dependent on PKC activation [9]. However, ster- 
oids and 1,25-dihydroxyvitamin D3 have been shown to induce 
NGF protein and mRNA by a mechanism different o serum 
and PMA, and independent of PKC and c-fos gene activation 
[22,24]. Although this indicates that the the control of NGF 
synthesis does not depend on a unique pathway, the different 
putative mechanisms up-regulating NGF synthesis operate by 
increasing the steady-state levels of intracellular NGF mRNA. 
In this report we demonstrate that a PC-PLC induces the 
synthesis of NGF by glial cells by a mechanism that is partially 
dependent on PKC activation. The fact that PC-PLC is able to 
produce an accumulation of NGF transcripts indicates that at 
least part of the stimulatory effect akes place at the pre-trans- 
lational evel. One of the particular features of the action of 
PC-PLC, alone or in combination with phosphatidate 
phosphohydrolase, is that the increase in intracellular DAG 
concentration is prolonged, indicating that it may be responsi- 
ble for long-term cellular responses [13]. Our results are in 
agreement with this notion since NGF is generally considered 
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to be coded by a late expression gene. Results also indicate that 
PC-PLC acts by at least wo different pathways, one dependent 
on PKC and another independent of PKC. We and others have 
previously found that PC-PLC triggers ome cellular esponses, 
namely induction of DNA synthesis or activation of nuclear 
transcription factor systems by a PKC-independent mechanism 
[17,24]. It has been described that PC-PLC is coupled to a 
sphingomyelinase that catalyzes the breakdown of sphingomy- 
elin into ceramide [24]. A second messenger function for the 
sphingomyelin cycle and ceramide in the control of cell growth, 
differentiation and apoptosis has been recently proposed [25]. 
Our data show that sphingosine induces NGF synthesis to a 
similar extent han the PKC-independent mechanism elicited 
by PC-PLC. The effect exerted by sphyngosine may be medi- 
ated by its conversion to ceramide, as it has been suggested for 
other biological responses mediated by sphingosine [26]. On the 
other hand, vitamin D3, which induces NGF by a PKC-inde- 
pendent mechanism, has been shown to elicit an early and 
reversible hydrolisis of sphingomyelin with a concomitant gen- 
eration of ceramide [27]. Two mechanisms may be therefore 
involved in the generation of NGF by astrocytes, one repre- 
sented by serum and DAG acting through PKC, and another 
one induced by vitamin D3 acting through the sphingomyelin 
cycle. Our results suggest that the breakdown of PC by a PLC 
may trigger both mechanisms. 
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